1 |
Aghaee F, Islamian JP, Baradaran B, et al (2013). Enhancing the effects of low dose doxorubicin treatment by the radiation in T47D and SKBR3 breast cancer cells. J Breast Cancer, 16, 164-70.
DOI
|
2 |
Dwarkanath BS, Zolzer F, Chandana S, et al (2001). Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines. Int J Radiat Oncol Biol Phys, 50, 1051-61.
DOI
|
3 |
El-Kassas HY, El-Sheekh MM (2014). Cytotoxic activity of biosynthesized gold nanoparticles with an extract of the red seaweed Corallina officinalis on the MCF-7 human breast cancer cell line. Asian Pac J Cancer Prev, 15, 4311.
DOI
|
4 |
Elstner E, Williamson EA, Zang C, et al (2002). Novel therapeutic approach: ligands for PPAR and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells. Breast Cancer Res Treat, 74, 155-65.
DOI
|
5 |
Ghilotti M, Pierotti MA, Gariboldi M (2010). Molecular markers for prediction of risk of radiation-related injury to normal tissue. J Nucleic Acids Investig, 1, 11.
DOI
|
6 |
Hainfeld JF, Slatkin DN, Focella TM, et al (2014). Gold nanoparticles: a new X-ray contrast agent. Br J Radiol, 79, 248-53.
|
7 |
Hou CH, Hou SM, Hsueh YS, et al (2009). The in vivo performance of biomagnetic hydroxyapatite nanoparticles in cancer hyperthermia therapy. Biomaterials, 30, 3956-60.
DOI
|
8 |
Issels RD, Lindner LH, Verweij J, et al (2010). Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol, 11, 561-70.
DOI
|
9 |
Jain S, Coulter JA, Hounsell AR, et al (2011). Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int J Radiat Oncol Biol Phys, 79, 531-9.
DOI
|
10 |
Jain S, Hirst DG, O'Sullivan JM (2014). Gold nanoparticles as novel agents for cancer therapy. Br J Radiol, 85, 101-13.
|
11 |
Quiles JL, Huertas JR, Battino M, et al (2002). Antioxidant nutrients and adriamycin toxicity. Toxicol, 180, 79-95.
DOI
ScienceOn
|
12 |
Schwarz SB, Schaffer PM, Kulka U, et al (2008). The effect of radio-adaptive doses on HT29 and GM637 cells. Radiat Oncol, 3, 1-6.
DOI
|
13 |
Selim ME, Hendi AA (2012). Gold nanoparticles induce apoptosis in MCF-7 human breast cancer cells. Asian Pac J Cancer Prev, 13, 1617-20.
DOI
ScienceOn
|
14 |
Takanashi S, Bachur NR (1976). Adriamycin metabolism in man. Evidence from urinary metabolites. Drug Metab Dispos, 4, 79-87.
|
15 |
Van der Zee J, Gonzalez D, van Rhoon GC, et al (2000). Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Lancet, 355, 1119-25.
DOI
|
16 |
Verma NK, Crosbie-Staunton K, Satti A, et al (2013). Magnetic core-shell nanoparticles for drug delivery by nebulization. J Nanobiotechnol, 11.
|
17 |
Vernon CC, Hand JW, Field SB, et al (1996). Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. Int J Radiat Oncol Biol Phys, 35, 731-44.
DOI
|
18 |
Warburg O (1956). The metabolism of tumors, Science, 123, 309-14.
DOI
|
19 |
Wust P, Hildebrandt B, Sreenivasa G, et al (2002). Hyperthermia in combined treatment of cancer. Lancet Oncol, 3, 487-97.
DOI
|
20 |
Yadav D, Anwar MF, Garg V, et al (2014). Development of polymeric nanopaclitaxel and comparison with free paclitaxel for effects on cell proliferation of MCF-7 and B16F0 carcinoma cells. Asian Pac J Cancer Prev, 15, 2335-40.
DOI
ScienceOn
|
21 |
Aghaee F, Pirayesh Islamian J, Baradaran B (2012). Enhanced radiosensitivity and chemosensitivity of breast cancer cells by 2-deoxy-d-glucose in combination therapy. J Breast Cancer, 15, 141-7.
DOI
|
22 |
Ahmad IM, Mustafa EH, Mustafa NH, et al (2010). 2DG enhances the susceptibility of breast cancer cells to doxorubicin. Cent Eur J Biol, 5, 739-48.
|
23 |
Aydogan B, Li J, Rajh T, et al (2010). AuNP-DG: deoxyglucoselabeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging. Mol Imaging Biol, 12, 463-7.
DOI
|
24 |
Basel MT, Balivada S, Wang H, et al (2012). Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. Int J Nanomedicine, 7, 297.
|
25 |
Casciaro S, Conversano F, Ragusa A, et al (2010). Optimal enhancement configuration of silica nanoparticles for ultrasound imaging and automatic detection at conventional diagnostic frequencies. Invest Radiol, 45, 715-24.
DOI
|
26 |
Chen Y, Wan Y, Wang Y, et al (2011). Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles. Int J Nanomedicine, 6, 2321.
|
27 |
Cheng G, Zielonka J, Dranka BP, et al (2012). Mitochondriatargeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. Cancer Res, 72, 2634-44.
DOI
|
28 |
Cho SH (2005). Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study. Phys Med Biol, 50, 163.
DOI
|
29 |
Cobb JP, Hotchkiss RS, Karl IE, et al (1996). Mechanisms of cell injury and death. Br J Anaesth, 77, 3-10.
DOI
|
30 |
Juzenas P, Chen W, Sun Y-P, et al (2008). Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev, 60, 1600-14.
DOI
|
31 |
Kaabinejadian S, Fouladdel SH, Ramezani M, et al (2008). p53 expression in MCF7, T47D and MDA-MB 468 breast cancer cell lines treated with adriamycin using RT-PCR and immunocytochemistry. J Biol Sci, 8, 380-5.
DOI
|
32 |
Kong Q, Lillehei KO (1998). Antioxidant inhibitors for cancer therapy. Med Hypotheses, 51, 405-9.
DOI
|
33 |
Loh SY, Chew SL (2011). Awareness and practice of breast self examination among Malaysian women with breast cancer. Asian Pac J Cancer Prev, 12,199-202.
|
34 |
Lu J, Ma S, Sun J, et al (2009). Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging. Biomaterials, 30, 2919-28.
DOI
|
35 |
McPherson K, Steel C, Dixon JM (2000). ABC of breast diseases: breast cancer-epidemiology, risk factors, and genetics. BMJ, 321, 624.
DOI
|
36 |
Mentis A-FA, Saha P, Das S, et al (2010). Metabolism and cancer: an up-to-date review of a mutual connection. Asian Pac J Cancer Prev, 11, 1437-44.
|
37 |
Mitra S, Gaur U, Ghosh PC, et al (2001). Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release, 74, 317-23.
DOI
|
38 |
Nahrendorf M, Zhang H, Hembrador S, et al (2008). Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation, 117, 379-87.
DOI
|
39 |
Nogueira DR, Rolim CMB, Farooqi AA (2014). Nanoparticle induced oxidative stress in cancer cells: adding new pieces to an incomplete jigsaw puzzle. Asian Pac J Cancer Prev, 15, 4739-43.
DOI
|
40 |
Yang WT, Le-Petross HT, Macapinlac H, et al (2008). Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat, 109, 417-26.
DOI
|
41 |
Yen SK, Padmanabhan P, Selvan ST (2013). Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery. Theranostics, 3, 986.
DOI
|
42 |
Yin H-T, Zhang DG, Wu XL, et al (2013). In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model. Asian Pac J Cancer Prev, 14, 409-12.
DOI
ScienceOn
|
43 |
Zhang X, Xing JZ, Chen J, et al (2008). Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles. Clin Invest Med, 31, 160-7.
|
44 |
Zheng Y, Hunting DJ, Ayotte P, et al (2009). Radiosensitization of DNA by gold nanoparticles irradiated with high-energy electrons. Radiat Res, 169, 19-27.
|